Cerebral Vascular Stent Market Trends and Forecast
The future of the global cerebral vascular stent market looks promising with opportunities in the hospital and medical center markets. The global cerebral vascular stent market is expected to grow with a CAGR of 8.6% from 2024 to 2030. The major drivers for this market are rising prevalence of cerebrovascular diseases, including strokes and aneurysms, innovations in stent design, materials, and manufacturing processes, and growing preference among patients and healthcare providers for minimally invasive procedures over traditional surgical interventions.
• Lucintel forecasts that tantalum is expected to witness the highest growth over the forecast period.
• Within this market, hospitals is expected to witness the higher growth.
• North America will remain the largest region over the forecast period.
Country Wise Outlook for the Cerebral Vascular Stent Market
• United States: Medtronic and Stryker Corporation have launched advanced cerebral vascular stents with improved navigational capabilities and biocompatibility, aiming to enhance treatment outcomes for patients. The FDA continues to support innovation through expedited approval processes for neurovascular devices.
• Germany: German government funding initiatives are supporting research and development in next-generation cerebral vascular stents. Companies like B. Braun Melsungen AG and Phenox GmbH are focusing on developing stents with enhanced flexibility and thrombogenicity profiles.
• China: Chinese companies such as MicroPort Scientific Corporation and Shanghai MicroPort Endovascular MedTech Group are expanding their portfolios with innovative cerebral vascular stents, targeting improved patient outcomes in neuro-interventional procedures. Government policies aim to improve access to advanced medical technologies nationwide.
• India: Indian healthcare providers are increasingly adopting cerebral vascular stents from international companies like Abbott Laboratories and Penumbra Inc. Local manufacturers are also entering the market with cost-effective stent solutions, supported by government initiatives to enhance healthcare infrastructure and affordability.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Cerebral Vascular Stent Market by Segment
The study includes a forecast for the global cerebral vascular stent market by type, application, and region.
Cerebral Vascular Stent Market by Type [Value from 2018 to 2030]:
• Tantalum
• Stainless Steel
• Nitinol
Cerebral Vascular Stent Market by Application [Value from 2018 to 2030]:
• Hospital
• Medical Centres
• Others
Cerebral Vascular Stent Market by Region [Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Cerebral Vascular Stent Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cerebral vascular stent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cerebral vascular stent companies profiled in this report include-
• Stryker Corporation
• Boston Scientific Corporation
• Johnson & Johnson Services
• Terumo Corporation
• Cook Medical
• Penumbra
• Medtronic plc
• Acandis GmbH
• Phenox GmbH
• MicroPort Scientific Corporation
Recent Development in the Cerebral Vascular Stent Market
• Medtronic: Medtronic has launched the Telescope™ Guide Extension Catheter and DiamondTemp™ Ablation Catheter for use in conjunction with its Pipeline™ Flex embolization device. These innovations aim to enhance precision and efficacy in treating complex cerebral vascular conditions such as aneurysms.
• Stryker Corporation: Stryker Corporation has introduced the Surpass Evolve Flow Diverter, designed to treat large and giant wide-necked intracranial aneurysms. This next-generation flow diverter offers improved navigational capabilities and optimized vessel wall apposition for better patient outcomes.
• Abbott Laboratories: Abbott Laboratories has expanded its neurovascular portfolio with the introduction of the NeuroPath™ Aneurysm Embolization Device. This device utilizes advanced braided technology to provide precise deployment and conformability in treating cerebral aneurysms, addressing clinical needs for durable occlusion.
• Boston Scientific Corporation: Boston Scientific Corporation has announced the launch of the Vercise™ Gevia™ Deep Brain Stimulation System in Europe. While not specifically a cerebral vascular stent, this system demonstrates the companyÄX%$%Xs commitment to advancing neurotechnology for treating movement disorders, potentially influencing future innovations in neurovascular interventions.
• MicroPort Scientific Corporation: MicroPort Scientific Corporation has received regulatory approval for its Firehawk™ Rapamycin Target Eluting Coronary Stent System in multiple countries. Although focused on coronary stents, this highlights the companyÄX%$%Xs capabilities and potential future developments in neurovascular stent technologies.
Features of the Global Cerebral Vascular Stent Market
Market Size Estimates: Cerebral vascular stent market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Cerebral vascular stent market size by type, application, and region in terms of value ($B).
Regional Analysis: Cerebral vascular stent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the cerebral vascular stent market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cerebral vascular stent market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for cerebral vascular stent market?
Answer: The global cerebral vascular stent market is expected to grow with a CAGR of 8.6% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the cerebral vascular stent market?
Answer: The major drivers for this market are rising prevalence of cerebrovascular diseases, including strokes and aneurysms, innovations in stent design, materials, and manufacturing processes, and growing preference among patients and healthcare providers for minimally invasive procedures over traditional surgical interventions.
Q3. What are the major segments for cerebral vascular stent market?
Answer: The future of the cerebral vascular stent market looks promising with opportunities in the hospital and medical center markets.
Q4. Who are the key cerebral vascular stent market companies?
Answer: Some of the key cerebral vascular stent companies are as follows:
• Stryker Corporation
• Boston Scientific Corporation
• Johnson & Johnson Services
• Terumo Corporation
• Cook Medical
• Penumbra
• Medtronic plc
• Acandis GmbH
• Phenox GmbH
• MicroPort Scientific Corporation
Q5. Which cerebral vascular stent market segment will be the largest in future?
Answer: Lucintel forecasts that tantalum is expected to witness the highest growth over the forecast period.
Q6. In cerebral vascular stent market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the cerebral vascular stent market by type (tantalum, stainless steel, and nitinol), application (hospital, medical centres, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Cerebral Vascular Stent Market Market, Cerebral Vascular Stent Market Market Size, Cerebral Vascular Stent Market Market Growth, Cerebral Vascular Stent Market Market Analysis, Cerebral Vascular Stent Market Market Report, Cerebral Vascular Stent Market Market Share, Cerebral Vascular Stent Market Market Trends, Cerebral Vascular Stent Market Market Forecast, Cerebral Vascular Stent Market Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.